Translate Bio announces FDA clinical hold on IND

Clinical Research |  News | 0 Comment | 23 Jan, 2019

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunct...Read more

Gamida Cell collaborates with Be The Match BioTherapies

Clinical Research |  News | 0 Comment | 23 Jan, 2019

Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and so...Read more

Redx to resume RXC004 clinical trial programme

Clinical Research |  News | 0 Comment | 22 Jan, 2019

UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval to the Company to re-commence the...Read more

Abcam, Loulou Foundation enters research collaboration for CDKL5 deficiency disorder

Clinical Research |  News | 0 Comment | 22 Jan, 2019

Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation dedicated to the development of therapeutics for CDKL5 Deficiency Diso...Read more

TaiwanJ Pharma announces new clinical results on AIH drug

Clinical Research |  News | 0 Comment | 22 Jan, 2019

TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical needs such as NASH and Cancers, recently ...Read more

Lilly reports results of ANNOUNCE

Clinical Research |  News | 0 Comment | 21 Jan, 2019

Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combination with doxorubicin in patients with advanced or metastatic soft tis...Read more

AIVITA gets IND nod for Phase 1B melanoma trial

Clinical Research |  News | 0 Comment | 17 Jan, 2019

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New ...Read more

United Neuroscience gets positive results from Ph2a trial for Alzheimer's vaccine

Clinical Research |  News | 0 Comment | 17 Jan, 2019

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders has announced positive top-line results from its Phase 2a...Read more

Bridge Bio receives FDA ODD for IPF drug

Clinical Research |  News | 0 Comment | 17 Jan, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@TMC in Houston, Texas, announced that the U.S. Food and Dr...Read more

Immunocore names David Berman as Head of R&D

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development. Over his career, David has worked on immuno-oncology programmes at ...Read more

Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has announced that the first patient has been successfully dosed in a pha...Read more

NIH starts clinical trial for FMT

Clinical Research |  News | 0 Comment | 15 Jan, 2019

A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema—putting stool from a healthy donor...Read more

UroGen Pharma announces positive results of UGN-101

Clinical Research |  News | 0 Comment | 14 Jan, 2019

A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has announced topline results from the ongoing pivotal Phase 3 OLYMPUS cl...Read more

CellMax, Medigen partner for cell therapy clinical trials

Clinical Research |  News | 0 Comment | 11 Jan, 2019

CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood, has been named as a partner in Taiwan based Medigen Biotech’s...Read more

Forbius announces the first patient dosed in a Phase 1 trial of AVID200

Clinical Research |  News | 0 Comment | 09 Jan, 2019

Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the first patient was dosed in a Phase 1 clinical trial with AVID200. The tri...Read more

Immutep collaborates with CYTLIMIC

Clinical Research |  News | 0 Comment | 08 Jan, 2019

Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and a service agreement with CYTLIMIC Inc.  for its lead product can...Read more

Solasia initiates Phase III programme for PledOx

Clinical Research |  News | 0 Comment | 07 Jan, 2019

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Solasia acquired exclusive development and commercialization rights for ...Read more

USFDA approves Portola Pharmaceuticals’ Andexxa®

Clinical Research |  News | 0 Comment | 03 Jan, 2019

Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Prior Approval Supplement (PAS) for its large-scale, second generatio...Read more